CD133 as Biomarker and Therapeutic Target in Gynecologic Malignancies
- 31 January 2023
- book chapter
- Published by Springer Nature
- p. 37-75
Abstract
No abstract availableKeywords
This publication has 239 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem CellsCell Stem Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cellsInternational Journal of Cancer, 2011
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of MetastasisStem Cells, 2010
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentCell, 2010
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cellsJournal of Molecular Medicine, 2008
- CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInternational Journal of Cancer, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006